Invitrogen™ Human CCDC22 Synthetic Peptide
CCDC22 Synthetic Peptide, PEP-1449, from Invitrogen.
- Gene ID (Enter)
- 28952
- Species
- Human
- Purification method
- Purified
- Accession number
- O60826
- Common name
- Human CCDC22
- Brand
- Invitrogen
CCDC22 Synthetic Peptide, PEP-1449, from Invitrogen.
CCDC22 Synthetic Peptide, PEP-1449, from Invitrogen.
CCDC22 is a recently identified coiled-coil domain-containing protein that has been shown to bind copines, which are calcium-dependent, membrane-binding proteins that may function in calcium signaling. In rat, CCDC22 has been observed to localize in multiple regions of the brain, including the prefrontal and somatosensory cortex, dentate gyrus and thalamus, and in the ipsilateral motor neurons of the spinal cord after sciatic nerve transection suggesting that it may play a role in neuronal injury response. The human CCDC22 gene has been identified as a novel candidate gene for syndromic X-linked intellectual disability (XLID).
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15245359 |
| Specifications | |
| Gene ID (Enter) | 28952 |
| Species | Human |
| Purification method | Purified |
| Accession number | O60826 |
| Common name | Human CCDC22 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | CCDC22 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1449 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |